- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/35 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
Patent holdings for IPC class C12N 15/35
Total number of patents in this class: 260
10-year publication summary
15
|
6
|
14
|
7
|
22
|
29
|
18
|
24
|
20
|
6
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Trustees of the University of Pennsylvania | 4122 |
21 |
University of Florida Research Foundation, Inc. | 3883 |
8 |
The University of North Carolina at Chapel Hill | 1928 |
8 |
The Children's Hospital of Philadelphia | 716 |
7 |
University of Massachusetts | 2130 |
7 |
uniQure IP B.V. | 120 |
5 |
University of Iowa Research Foundation | 809 |
5 |
Deutsches Krebsforschungszentrum | 417 |
4 |
Genethon | 243 |
4 |
REGENXBIO Inc. | 232 |
4 |
The Regents of the University of California | 18943 |
3 |
Centre National de La Recherche Scientifique | 9632 |
3 |
Takeda Pharmaceutical Company Limited | 2961 |
3 |
Genzyme Corporation | 1205 |
3 |
Massachusetts Eye and Ear Infirmary | 348 |
3 |
Regeneron Pharmaceuticals, Inc. | 3650 |
3 |
Schepens Eye Research Institute | 64 |
3 |
Takara Bio Inc. | 245 |
3 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
3 |
University of Kansas | 838 |
3 |
Other owners | 157 |